Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#91 / 122 Total
CVAC - CureVac N.V. - Stock Price Chart
CompanyCureVac N.V.
Market Cap541.79MEPS (ttm)-1.53
P/E-EPS this Y29.93%
Forward P/E-EPS next Y34.59%
PEG-EPS past 5Y-32.46%
P/S11.84EPS next 5Y-10.76%
P/B0.85EPS Q/Q6.41%
Dividend-Sales Q/Q58.86%
Insider Own59.08%Inst Own10.02%
Insider Trans0.00%Inst Trans-2.61%
Short Float5.47%EarningsNov 14/b
Analyst Recom2.67Target Price7.56
Avg Volume779.85K52W Range2.36 - 12.36
CureVac BV is a clinical-stage biopharmaceutical company, which engages in developing transformative medicines based on messenger ribonucleic acid (mRNA). Its product portfolio includes clinical and preclinical candidates across multiple disease indications in prophylactic vaccines, oncology, and protein therapy. The company was founded by Ingmar Hoerr and Florian von der Mulbe in 2000 and is headquartered in Tubingen, Germany.
PLRX - Pliant Therapeutics Inc - Stock Price Chart
CompanyPliant Therapeutics Inc
Market Cap716.86MEPS (ttm)-2.75
P/E-EPS this Y-19.40%
Forward P/E-EPS next Y-7.78%
PEG-EPS past 5Y-22.68%
P/S453.71EPS next 5Y-
P/B1.51EPS Q/Q4.52%
Dividend-Sales Q/Q-100.00%
Insider Own12.44%Inst Own95.72%
Insider Trans-0.80%Inst Trans36.14%
Short Float14.15%EarningsFeb 27/a
Analyst Recom1.00Target Price43.00
Avg Volume360.80K52W Range12.00 - 30.85
Pliant Therapeutics, Inc. engages in the discovery and development of therapies for fibrotic diseases. It offers product discovery engine. The company is pursuing drug development programs for a range of fibrotic diseases, focusing on tissue-specific integrin modulation and TGF-ß1 signaling inhibition. The company was founded by Bradley Backes, Bill De Grado, Hal Chapman, and Dean Sheppard in June 2015 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Coulie BernardPresident and CEOJan 17 '24Sale17.2325,721443,173316,382Jan 19 05:19 PM
Lefebvre EricChief Medical OfficerJan 17 '24Sale17.2310,295177,383156,920Jan 19 05:18 PM
Hull HansChief Business OfficerJan 17 '24Sale17.239,786168,613185,069Jan 19 05:19 PM
Cummings Keith LamontChief Financial OfficerJan 17 '24Sale17.239,781168,527194,605Jan 19 05:19 PM
Ouimette MikeGeneral Counsel & Corp. Sec'yJan 17 '24Sale17.235,19789,54455,246Jan 19 05:11 PM
AHT - Ashford Hospitality Trust Inc - Stock Price Chart
TickerAHT [NYSE]
CompanyAshford Hospitality Trust Inc
IndustryREIT - Hotel & Motel
Market Cap50.23MEPS (ttm)-5.62
P/E-EPS this Y-15.17%
Forward P/E-EPS next Y40.63%
PEG-EPS past 5Y49.75%
P/S0.04EPS next 5Y5.00%
P/B-EPS Q/Q48.64%
Dividend-Sales Q/Q0.76%
Insider Own1.33%Inst Own29.65%
Insider Trans0.00%Inst Trans4.83%
Short Float7.09%EarningsMay 07/a
Analyst Recom2.50Target Price3.83
Avg Volume598.75K52W Range1.24 - 5.09
Ashford Hospitality Trust, Inc. is a real estate investment trust, which invests in the hospitality industry. The firm's investments include direct hotel, mezzanine financing through origination or acquisition, first mortgage financing through origination or acquisition, sale-leaseback transactions and other hospitality transactions. The company was founded by Montgomery Jack Bennett in May 2003 and is headquartered in Dallas, TX.
BLDP - Ballard Power Systems Inc. - Stock Price Chart
CompanyBallard Power Systems Inc.
IndustrySpecialty Industrial Machinery
Market Cap756.57MEPS (ttm)-0.59
P/E-EPS this Y10.61%
Forward P/E-EPS next Y8.55%
PEG-EPS past 5Y-32.26%
P/S7.39EPS next 5Y0.03%
P/B0.76EPS Q/Q-48.61%
Dividend-Sales Q/Q125.47%
Insider Own19.10%Inst Own22.18%
Insider Trans0.00%Inst Trans-0.77%
Short Float9.59%EarningsMay 07/b
Analyst Recom3.05Target Price4.41
Avg Volume3.03M52W Range2.53 - 5.68
Ballard Power Systems, Inc. engages in the design, development, manufacture, sale, and service of fuel cell products. It focuses on power products for bus, truck, rail, marine, stationery, and emerging markets applications, as well as the delivery of services, including technology solutions, after sales services, and training. The company was founded in 1979 and is headquartered in Burnaby, Canada.
SPEC - Spectaire Holdings Inc - Stock Price Chart
CompanySpectaire Holdings Inc
IndustryPollution & Treatment Controls
Market Cap8.82MEPS (ttm)0.15
P/E3.96EPS this Y92.04%
Forward P/E1.63EPS next Y293.59%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q807.17%
Dividend-Sales Q/Q-
Insider Own23.05%Inst Own8.87%
Insider Trans0.35%Inst Trans9.07%
Short Float0.28%Earnings-
Analyst Recom3.00Target Price1.80
Avg Volume1.04M52W Range0.52 - 15.40
Spectaire Holdings, Inc. is an industrial technology company that allows its customers to measure, manage, and reduce carbon dioxide equivalent (CO2e) and other greenhouse gas emissions. It offers AireCore, is a fully integrated hardware, software, and data platform. The company was founded in 2022 and is headquartered in Watertown, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Semkiw BrianChairman & CEOOct 25 '23Buy2.232976611,715,528Oct 26 07:25 PM
Mosolf JoergDirectorOct 24 '23Buy3.0010,00030,00010,000Oct 26 07:26 PM
Semkiw BrianChairman & CEOOct 24 '23Buy1.941,8993,6851,715,231Oct 26 07:25 PM
Owl Creek Asset Management, L.10% OwnerAug 17 '23Sale11.05160,0001,768,00079,323Aug 21 06:21 PM
KYTX - Kyverna Therapeutics Inc. - Stock Price Chart
CompanyKyverna Therapeutics Inc.
Market Cap762.98MEPS (ttm)-
P/E-EPS this Y96.35%
Forward P/E-EPS next Y-22.14%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
Dividend-Sales Q/Q-
Insider Own29.61%Inst Own3.25%
Insider Trans19.27%Inst Trans-
Short Float4.77%EarningsMar 26/a
Analyst Recom1.00Target Price42.75
Avg Volume493.11K52W Range17.76 - 35.06
Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company. It develops treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GILEAD SCIENCES, INC.10% OwnerFeb 12 '24Buy22.00910,00020,020,0004,126,119Feb 13 05:48 PM
Northpond Ventures III GP, LLCFormer 10% OwnerFeb 12 '24Buy22.00450,0009,900,000450,000Feb 12 05:51 PM
Bain Capital Life Sciences Inv10% OwnerFeb 12 '24Buy22.00450,0009,900,0003,163,868Feb 14 05:26 PM
Vida Ventures, LLC10% OwnerFeb 12 '24Buy22.00253,1365,568,992252,553Feb 14 07:04 PM
UBX - Unity Biotechnology Inc - Stock Price Chart
TickerUBX [NASD]
CompanyUnity Biotechnology Inc
Market Cap25.02MEPS (ttm)-2.93
P/E-EPS this Y21.67%
Forward P/E-EPS next Y9.69%
PEG-EPS past 5Y36.93%
P/S-EPS next 5Y-
P/B0.88EPS Q/Q72.50%
Dividend-Sales Q/Q-
Insider Own8.66%Inst Own18.69%
Insider Trans-0.24%Inst Trans116.18%
Short Float2.00%EarningsApr 15/b
Analyst Recom1.00Target Price7.00
Avg Volume90.14K52W Range1.47 - 3.82
Unity Biotechnology, Inc. operates as a biotechnology company. The firm is developing a portfolio of programs like biological mechanisms implicated in diseases of aging, and also senolytic programs in ophthalmologic and neurologic disorders. The company was founded by Nathaniel Eames David, Jan van Deursen, Judith Campisi, and Daohong Zhou on March 30, 2009 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ghosh AnirvanChief Executive OfficerFeb 02 '24Sale1.716801,16378,746Feb 05 04:05 PM
Ghosh AnirvanChief Executive OfficerJan 30 '24Sale1.711,1832,02379,426Jan 31 04:05 PM
Ghosh AnirvanChief Executive OfficerNov 02 '23Sale1.835891,07880,609Nov 03 04:05 PM
Ghosh AnirvanChief Executive OfficerOct 30 '23Sale1.901,0241,94681,198Oct 31 04:05 PM
Ghosh AnirvanChief Executive OfficerSep 14 '23Sale2.471,2463,07882,222Sep 15 04:08 PM
AKAN - Akanda Corp - Stock Price Chart
CompanyAkanda Corp
CountryUnited Kingdom
IndustryDrug Manufacturers - Specialty & Generic
Market Cap1.09MEPS (ttm)-4.08
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.28EPS next 5Y-
P/B0.02EPS Q/Q-62.56%
Dividend-Sales Q/Q1811.79%
Insider Own11.42%Inst Own0.50%
Insider Trans0.00%Inst Trans-92.54%
Short Float0.02%Earnings-
Analyst Recom-Target Price-
Avg Volume4.39M52W Range0.09 - 2.70
Akanda Corp. is a cannabis cultivation, manufacturing, and distribution company, which engages in the provision of premium quality and ethically sourced medical cannabis products to patients. The company cultivates and processes natural cannabis at facilities in the Kingdom of Lesotho, Africa and intend to supply medicinal-grade cannabis biomass, cannabis flower, and cannabis concentrates to wholesalers. It also imports and sells medical cannabis-based products. The company was founded on July 16, 2021 and is headquartered New Romney, the United Kingdom.
SLRN - Acelyrin Inc - Stock Price Chart
CompanyAcelyrin Inc
Market Cap449.51MEPS (ttm)-3.92
P/E-EPS this Y24.27%
Forward P/E-EPS next Y-15.86%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.68EPS Q/Q-526.06%
Dividend-Sales Q/Q-
Insider Own37.98%Inst Own73.12%
Insider Trans-0.10%Inst Trans-
Short Float13.03%EarningsMar 28/a
Analyst Recom1.40Target Price31.00
Avg Volume1.25M52W Range4.59 - 29.88
ACELYRIN, Inc. operates as a biopharma company. It engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company was founded by Shao-Lee Lin on July 27, 2020 and is headquartered in Agoura Hills, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lin Shao-LeeChief Executive OfficerApr 01 '24Sale6.639,96166,0241,577,374Apr 03 06:18 PM
Lin Shao-LeeChief Executive OfficerFeb 20 '24Sale7.6015,701119,4031,587,335Feb 22 07:04 PM
Lin Shao-LeeChief Executive OfficerJan 02 '24Sale7.4110,69179,1881,603,036Jan 04 06:09 PM
Westlake BioPartners Fund II, 10% OwnerMay 09 '23Buy18.001,250,00022,500,0009,790,729May 11 09:16 PM
SEIDENBERG BETH CDirectorMay 09 '23Buy18.001,250,00022,500,0009,790,729May 11 09:13 PM
TLK - Telkom Indonesia (Persero) Tbk PT ADR - Stock Price Chart
TickerTLK [NYSE]
CompanyTelkom Indonesia (Persero) Tbk PT ADR
IndustryTelecom Services
Market Cap19.23BEPS (ttm)1.60
P/E12.16EPS this Y7.14%
Forward P/E11.01EPS next Y5.77%
PEG1.05EPS past 5Y4.80%
P/S1.96EPS next 5Y11.60%
P/B2.14EPS Q/Q-8.22%
Dividend6.12%Sales Q/Q1.01%
Insider Own0.01%Inst Own3.86%
Insider Trans0.00%Inst Trans-
Short Float0.09%EarningsApr 19/b
Analyst Recom1.59Target Price25.62
Avg Volume227.68K52W Range19.36 - 29.44
PT Telkom Indonesia (Persero) Tbk is a holding company, which engages in the provision of telecommunications, information, and technology services. It operates through the following segments: Mobile, Consumer, Enterprise, Wholesale and International Business (WIB), and Others. The Mobile segment provides mobile voice, SMS, value added services and, mobile broadband. The Consumer segment offers fixed wire line telecommunications services, pay television, data, and internet services to home customers. The Enterprise segment provides end-to-end solution to corporate and institutions. The WIB segment is composed of interconnection services, leased lines, satellite, VSAT, broadband access, information technology services, data and Internet services to Other Licensed Operator companies and institutions. The Others segment deals with Digital Service Operating Segments that does not meet the disclosure requirements for a reportable segments. The company was founded on September 24, 1991 and is headquartered in Jakarta, Indonesia.